Suppression of vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer
S. Kamiya, Y. Nakamori, A. Takasawa, K. Takasawa, D. Kyuno, Y. Ono, K. Magara, M. Osanai
This study shows that suppressing CYP24A1 increases breast cancer cell sensitivity to chemotherapeutic drugs like cisplatin and gefitinib.
bioRxiv · Oct 18, 2022Pathology